Detection and characterization of VIM-31, a new variant of VIM-2 with Tyr224His and His252Arg mutations, in a clinical isolate of Enterobacter cloacae.

Pierre Bogaerts, Carine Bebrone, Te-Din Huang, Warda Bouchahrouf, Yves Degheldre, Ariane Deplano, Kurt Hoffmann, Youri Glupczynski

Laboratory of Bacteriology, CHU Mont-Godinne, Université Catholique de Louvain, Yvoir, Belgium.

Antimicrobial agents and chemotherapy 2012 Jun

filter terms:

We report the first description of the metallo-β-lactamase VIM-31, a new variant of VIM-2 with Tyr224His and His252Arg mutations, in Enterobacter cloacae 11236, which was isolated from blood specimens of a patient with colonic adenocarcinoma in Belgium. bla(VIM-31) was found on a class 1 integron located on a self-transferable but not typeable 42-kb plasmid. Compared to values published elsewhere for VIM-2, the purified VIM-31 enzyme showed weaker catalytic efficiency against all the tested beta-lactam agents (except for ertapenem), resulting from lower k(cat) (except for ertapenem) and higher K(m) values for VIM-31.

Citation

Pierre Bogaerts, Carine Bebrone, Te-Din Huang, Warda Bouchahrouf, Yves Degheldre, Ariane Deplano, Kurt Hoffmann, Youri Glupczynski. Detection and characterization of VIM-31, a new variant of VIM-2 with Tyr224His and His252Arg mutations, in a clinical isolate of Enterobacter cloacae. Antimicrobial agents and chemotherapy. 2012 Jun;56(6):3283-7